These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23112394)

  • 1. Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin.
    Vijaya C; Goud KS
    Indian J Pharm Sci; 2011 Nov; 73(6):615-20. PubMed ID: 23112394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
    Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
    Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.
    Itoh K; Hatakeyama T; Shimoyama T; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2011 Jul; 37(7):790-7. PubMed ID: 21405940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate.
    Gupta S; Vyas SP
    Sci Pharm; 2010; 78(4):959-76. PubMed ID: 21179328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose.
    Kumar S; Himmelstein KJ
    J Pharm Sci; 1995 Mar; 84(3):344-8. PubMed ID: 7616375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
    Senjoti FG; Timmins P; Conway BR; Smith AM
    Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride.
    Mandal S; Thimmasetty MK; Prabhushankar G; Geetha M
    Int J Pharm Investig; 2012 Apr; 2(2):78-82. PubMed ID: 23119236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
    Balasubramaniam J; Pandit JK
    Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
    Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
    Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
    Khan N; Aqil M; Imam SS; Ali A
    Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
    Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
    Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ gelling pectin formulations for oral drug delivery at high gastric pH.
    Itoh K; Hirayama T; Takahashi A; Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2007 Apr; 335(1-2):90-96. PubMed ID: 17141988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
    Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
    Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
    Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
    Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
    Srividya B; Cardoza RM; Amin PD
    J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride.
    Makwana SB; Patel VA; Parmar SJ
    Results Pharma Sci; 2016; 6():1-6. PubMed ID: 26949596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Characterization of Thermosensitive and Bioadhesive Ophthalmic Formulations Containing Flurbiprofen Solid Dispersions.
    Adısanoğlu P; Özgüney I
    Gels; 2024 Apr; 10(4):. PubMed ID: 38667685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
    Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
    Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.